Literature DB >> 4061057

Supravaginal uterine amputation versus hysterectomy with reference to subjective bladder symptoms and incontinence.

P Kilkku.   

Abstract

Studies on postoperative symptoms of hysterectomy have devoted scarcely any attention to malfunctioning micturition and pressure sensation in the bladder region. Postoperative occurrence of incontinence is mentioned in some studies. Preoperatively, 33.3% of abdominal hysterectomy patients and 38.3% of patients with supravaginal uterine amputation complained of pressure sensation in the bladder region; one year after operation the corresponding percentages were 9.6 and 10.3. Prior to the operation, a sensation of residual urine after micturition occurred in 28.6% of hysterectomy patients and 35.5% of supravaginal amputation patients; at 1 year postoperatively these figures were 22.1 and 10.3% respectively. The decrease in the supravaginal amputation group is statistically highly significant. Preoperative incontinence occurred in 36.2% of hysterectomy and 47.7% of supravaginal amputation patients. Twelve months postoperatively the values were 28.8 and 22.6% respectively, the decrease in the supravaginal amputation group being again statistically highly significant. Development of log-linear models for both groups gave interactions "earlier urinary tract infections/sensation of residual urine" and "earlier urinary tract infections/incontinence". Thus the greater reduction in the symptoms in the supravaginal amputation group appears to result rather from the type of operation than from the differences in the two patient groups.

Entities:  

Mesh:

Year:  1985        PMID: 4061057     DOI: 10.3109/00016348509155151

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  8 in total

1.  Effects of vaginal hysterectomy on anorectal sensorimotor functions--a prospective study.

Authors:  A E Bharucha; C J Klingele; B M Seide; J B Gebhart; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2011-12-12       Impact factor: 3.598

2.  Long-Term Outcomes of the Total or Supracervical Hysterectomy (TOSH) Trial.

Authors:  W Jerod Greer; Holly E Richter; Thomas L Wheeler; R Edward Varner; Jeff M Szychowski; Miriam Kuppermann; Lee A Learman
Journal:  Female Pelvic Med Reconstr Surg       Date:  2010-01       Impact factor: 2.091

3.  Lower urinary tract symptoms after total and subtotal hysterectomy: results of a randomized controlled trial.

Authors:  Helga Gimbel; Vibeke Zobbe; Birthe Jakobsen Andersen; Helle Christina Sørensen; Kim Toftager-Larsen; Katrine Sidenius; Nini Møller; Ellen Merete Madsen; Mogens Vejtorp; Helle Clausen; Annie Rosgaard; John Villumsen; Christian Gluud; Bent S Ottesen; Ann Tabor
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005 Jul-Aug

4.  The short-term prevalence of de novo urinary symptoms after different modes of hysterectomy.

Authors:  Gudrun Neumann; Peter Grønning Olesen; Villy Hansen; Finn Friis Lauszus; Britt Ljungstrøm; Kjeld Leisgård Rasmussen
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-12-19

5.  Laparoscopic supracervical hysterectomy compared with abdominal, vaginal, and laparoscopic vaginal hysterectomy in a primary care hospital setting.

Authors:  John L Washington
Journal:  JSLS       Date:  2005 Jul-Sep       Impact factor: 2.172

6.  Problems related to the cervical stump at follow-up in laparoscopic supracervical hysterectomy.

Authors:  J G van der Stege; J J van Beek
Journal:  JSLS       Date:  1999 Jan-Mar       Impact factor: 2.172

7.  Supracervical hysterectomy versus total abdominal hysterectomy: perceived effects on sexual function.

Authors:  Jyot Saini; Edward Kuczynski; Herbert F Gretz; E Scott Sills
Journal:  BMC Womens Health       Date:  2002       Impact factor: 2.809

8.  Robotic Trachelectomy After Supracervical Hysterectomy for Benign Gynecologic Disease.

Authors:  Ziv Tsafrir; Joelle Aoun; Rabbie Hanna; Eleni Papalekas; Lauren Schiff; Evan Theoharis; David Eisenstein
Journal:  JSLS       Date:  2016 Jul-Sep       Impact factor: 2.172

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.